GH
Gilde Healthcare
Venture CapitalActiveGilde Healthcare is a healthcare investor that does lower mid-market buyouts and later stage venture.
77
Investments
7
Exits
$2.3B
AUM
9.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Gilde Healthcare.
Investment Thesis & Strategy
Gilde Healthcare invests in later-stage biotech, fintech, healthcare, health diagnostics, and home healthcare companies, with a focus on lower mid-market buyouts and later-stage venture opportunities.
Investment Activity
Deals per year over the last 8 years
4
20142
20152
20161
20172
20180
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 77 companies
A
Agomab Therapeutics
Biotech · Series A, 2021
X
XtalPi
Biotech · Growth, 2018
B
Bionomics
Biotech · Growth, 2018
i
iTeos Therapeutics
Biotech · Series B, 2017
C
Compugen
Biotech · Growth, 2016
M
Mapi Pharma
Biotech · Growth, 2016
O
ObsEva
Biotech · Growth, 2015
H
Hookipa Pharma
Biotech · Series B, 2015
A
Acacia Pharma
Biotech · Growth, 2014
P
ProQR Therapeutics
Biotech · Series B, 2014
S
Sequana Medical
Healthcare · Growth, 2014
V
Vectura
Biotech · Growth, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
Agomab TherapeuticsIPO2024—
AM-PharmaAcquisition2023—
ObsEvaIPO2016—
MerusIPO2016—
Acerta PharmaAcquisition2015$7B
BBIAcquisition2015—
uniQureIPO2012—
Frequently Asked Questions
Gilde Healthcare focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Holland Startup
Utrecht, The Netherlands · 3 deals
Bessemer Venture Partners
Redwood City, United States · 971 deals
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Index Ventures
San Francisco, United States · 827 deals
Andreessen Horowitz
Menlo Park, United States · 826 deals